Chordia Therapeutics (190A.TSE) Q1 2026 Earnings

14JanConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-6
-6
-5
-4

Details

Expected EPS
N/A
Actual EPS
-4
Surprise EPS
-4
Surprise Percent
+∞%

Description

Chordia Therapeutics (190A.TSE) has reported earnings of -4 per share for Q1 2026.

0 Comments

Share your thoughts